Jessica Rendall is a reporter with experience covering a variety of health and wellness topics, including chronic disease, ...
If you’re considering taking a GLP-1 (glucagon-like peptide-1) receptor agonist for weight loss, here’s what to know about the long-term benefits and risks, along with insights from physicians. GLP-1 ...
The same drugs that transformed obesity treatment are now being investigated for substance use disorders, fueling interest in ...
The federal government is rolling out a new program that will enable some Medicare recipients to access GLP-1 weight loss ...
This week's Pharma Pulse covers the launch of Medicare's GLP-1 Bridge, FDA's approval of the first regulatory T-cell therapy for chronic GVHD, seven companies tapped for FDA's PreCheck manufacturing ...
The federal government has launched a new program to make GLP-1 weight loss drugs more affordable for older Americans.
Welcome to the “Temu experience of telehealth,” where everyone from Grindr to MAGA influencers can open a virtual clinic ...
CELL, a premier innovator in cellular health and anti-aging biotechnology, today announced the launch of its advanced metabolic support synbiotic (Prebiotic and Probiotic) supplement. This pioneering ...
Germany's Planet A Foods has introduced a no-added-sugar version of its cocoa-free chocolate, ChoViva, to meet the demand for ...
A new oral GLP-1 medication helped people with type 2 diabetes dramatically improve blood sugar control and lose weight in a major clinical trial. The results suggest that highly effective diabetes ...
Walk into almost any supermarket today, and you are bound to witness an industry in the middle of a massive, quiet reinvention. For decades, the grocery business model operated on a straightforward, ...
Share on Pinterest AstraZeneca’s new oral GLP-1 pill showed promising results for weight loss and blood sugar in a phase 2 trial. Guido Mieth/Getty Images A new GLP-1 oral medication from AstraZeneca, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results